Watch AETN. Know when insiders buy.
One email the day a filing lands. Free.
AETN
AETERNUM HEALTH, INC.
0.15
+0.00 +0.00%
USD · close Sep 4
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
50
WATCH · shorts 50
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $14.8MP/E 7.6DIV YIELD —FCF YIELD —REV TTM —NET INCOME $1.3MNET CASH —52W 0.01 – 0.23SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$271K | $1.7M | — | 0.03 | −$1.5M | — | — | Aug 19 |
| Q1 2026 · Mar 31 | $2K | −98.6% | -530.0% | −$120K | −$140K | −2470.7% | 0.00 | −$56K | — | — | Aug 19 |
| Q4 2025 · Dec 31derived | $24K | +90.7% | 38.1% | −$82K | −$99K | — | -0.01 | −$39K | — | — | Mar 31 |
| Q3 2025 · Sep 30 | $8K | −46.0% | -103.3% | −$121K | −$138K | — | 0.00 | $36K | — | — | Nov 13 |
| Q2 2025 · Jun 30 | $7K | −78.7% | -79.2% | −$89K | −$106K | — | 0.00 | $18K | — | — | Aug 19 |
| Q1 2025 · Mar 31 | $165K | +4190.2% | 76.1% | $23K | $6K | — | 0.01 | −$18K | — | — | Aug 19 |
| Q4 2024 · Dec 31derived | $12K | +954.9% | -17.9% | −$122K | −$139K | — | -0.01 | −$1K | — | — | Mar 31 |
| Q3 2024 · Sep 30 | $15K | +5862.2% | -96.4% | −$110K | −$77K | — | 0.00 | −$8K | — | — | Nov 13 |
| Q2 2024 · Jun 30 | $33K | — | 97.5% | −$93K | −$116K | — | 0.00 | −$45K | — | — | Nov 13 |
| Q1 2024 · Mar 31 | $4K | — | -229.4% | −$105K | −$118K | — | 0.00 | −$100K | — | — | Nov 13 |
| Q1 2024 · Feb 29derived | $1K | — | -1758.0% | −$104K | −$131K | — | 0.00 | −$63K | — | — | Jun 13 |
| Q4 2023 · Dec 31derived | $259 | — | 1010.8% | −$69K | −$88K | — | 0.00 | −$145K | — | — | Sep 3 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $204K | 58.9% | −$269K | −$337K | -165.5% | -0.01 | −$3K | — | — | — | — |
| FY2024 · to Dec 31 | $65K | -19.5% | −$430K | −$450K | -691.5% | -0.01 | −$154K | — | — | — | — |
| FY2024 · to Feb 29 | $20K | -181.9% | −$584K | −$662K | -3375.7% | -0.01 | −$342K | — | — | — | — |
| FY2023 · to Dec 31 | $20K | -164.2% | −$552K | −$633K | -3147.6% | -0.01 | −$267K | — | — | — | — |
| FY2023 · to Feb 28 | $22K | -104.3% | −$259K | −$316K | -1416.1% | -0.01 | −$303K | — | — | — | — |
| FY2022 · to Feb 28 | $5K | — | −$304K | −$2.1M | -41467.8% | -0.36 | −$118K | — | — | — | — |
Every number comes from AETERNUM HEALTH, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.